Is Probiotics Blood Pressure Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Probiotics Blood Pressure Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Gut microbiota, a new approach to management of polycystic ovary syndrome: a systematic review, meta-analysis and meta-evidence of 26 randomized controlled trials. [Yin T (2026); evidence level 1] - Trial sequential analysis confirmed that the evidence for LDL-C and insulin was sufficient to reach firm conclusions. [Zhong Y (2026); evidence level 1] - Conclusion Probiotics have been shown to significantly reduce LDL-C and insulin levels in patients with CHD without increasing the risk of adverse events. [Zhong Y (2026); evidence level 1] - Objective This study aims to investigate the effects of probiotic supplementation on blood glucose, lipids and pressure in patients with coronary heart disease (CHD) through systematic review and meta-analysis, combined with sequential trial analysis, and to assess its safety. [Zhong Y (2026); evidence level 1] - Methods A systematic search was conducted across five English-language databases: PubMed, Embase, Cochrane Library, Web of Science, and MEDLINE. [Zhong Y (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.